LifeMD, Inc.
LFMD
$3.40
$0.133.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 28.88% | 27.64% | 33.67% | -14.74% | -11.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.88% | 27.64% | 33.67% | -14.74% | -11.63% |
| Cost of Revenue | -8.02% | 4.89% | 32.50% | 45.97% | 35.57% |
| Gross Profit | 36.37% | 31.80% | 33.85% | -21.71% | -17.46% |
| SG&A Expenses | 37.11% | 27.03% | 19.58% | -24.19% | -19.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 33.47% | 45.93% | 34.02% | 30.07% | 26.11% |
| Total Operating Expenses | 29.89% | 24.63% | 21.87% | -16.02% | -12.48% |
| Operating Income | -41.74% | 6.94% | 67.67% | 30.94% | 21.44% |
| Income Before Tax | -29.35% | 7.01% | 59.63% | 22.23% | 19.15% |
| Income Tax Expenses | -69.40% | -69.40% | -69.40% | -19.06% | 39.72% |
| Earnings from Continuing Operations | -25.75% | 9.07% | 59.88% | 22.12% | 17.89% |
| Earnings from Discontinued Operations | 441.12% | 1,049.97% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 81.24% | 23.66% | -130.59% | -113.99% | 28.93% |
| Net Income | 101.76% | 138.22% | 167.05% | 47.79% | 47.39% |
| EBIT | -41.74% | 6.94% | 67.67% | 30.94% | 21.44% |
| EBITDA | -32.56% | 13.89% | 72.93% | 26.91% | 16.42% |
| EPS Basic | 83.15% | 112.42% | 139.26% | 46.92% | 48.08% |
| Normalized Basic EPS | 0.27% | 22.65% | 61.01% | 26.40% | 29.57% |
| EPS Diluted | 83.04% | 111.92% | 138.60% | 46.42% | 47.57% |
| Normalized Diluted EPS | 0.27% | 22.65% | 61.01% | 26.40% | 29.57% |
| Average Basic Shares Outstanding | 10.14% | 10.15% | 10.20% | 9.78% | 12.51% |
| Average Diluted Shares Outstanding | 10.14% | 10.15% | 10.20% | 9.78% | 12.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 57.69% | 3.62% | 2.49% | -0.92% | -0.90% |